Takeda Patents definition

Takeda Patents means all Patents in the Territory Controlled by Takeda as of the Effective Date or during the Term that: (a) claim the composition of matter of, or the method of making or using, a Product; or (b) are otherwise reasonably necessary to Exploit the Compound or a Product in the Field in the Territory. The Takeda Patents as of the Effective Date are set forth on Exhibit C.
Takeda Patents means the Licensed [***] Patent and any Patent that claims priority (in accordance with Section 1.129) to the Licensed [***] Patent during the Term, and the Ultragenyx Pipeline Improvement Patents Controlled by Takeda or its Affiliates. The Takeda Patents as of the Execution Date are set forth on Exhibit 1.168.
Takeda Patents means the Takeda Compound Patents and the Takeda General Patents.

Examples of Takeda Patents in a sentence

  • Takeda shall be responsible for the preparation, prosecution (including any interferences, reissue proceedings and reexaminations) and maintenance of Takeda Patents.

  • Takeda shall have the right to terminate this Agreement immediately upon written notice if Orexigen directly or through a Third Party indirectly challenges the validity, scope or enforceability of or otherwise opposes any Patent included in the Takeda Patents or any foreign counterparts thereof.

  • Takeda shall have the sole right, but not the obligation, to bring an appropriate suit or other action against any person or entity allegedly infringing any Takeda Patents.

  • This would be upgraded and widened to 6.7 metres together with a 1.2 m wide footway to the southern side and retention of the existing public footpath leading to Kingsley Walk.

  • Governmental entity" has the same meaning as in Title 14, section 8102, subsection 2.[ 2013, c.


More Definitions of Takeda Patents

Takeda Patents means all Patents Controlled by Takeda or any of its Affiliates as of the Effective Date that are necessary or useful to Exploit the Compound or any Product in the Field in the Territory. Takeda Patents are set forth on Exhibit B. “Takeda Patents” excludes any Patents that are not Controlled by Takeda or any of its Affiliates as of the Effective Date (even if such Patents are Controlled by Takeda or any of its Affiliates at any time during the Term after the Effective Date). Notwithstanding the foregoing, “Takeda Patents” shall include any Patent Controlled by Takeda or any of its Affiliates at any time during the Term that claims an Invention that is necessary or useful to Exploit the Compound or any Product in the Field in the Territory and is conceived and/or reduced to practice solely by, or on behalf of, Takeda or any of its Affiliates in the course of Takeda’s conduct of the Research Material Synthesis Activities.
Takeda Patents means all Patents owned or Controlled by Takeda (including Takeda’s interest in Joint Patents and Patents Covering Takeda’s Inventions), as of the Effective Date or during the Term, that: (i) Cover the composition of matter of, or the method of making or using, the sale or the importation of the Compounds or the Products; or (ii) are otherwise used by Takeda to Exploit the Compounds or the Products in the Field in the Territory. To the extent that the foregoing sentence would cause “Takeda Patents” to include any Patents owned or Controlled by Takeda that Cover the use of a Compound or a Product (which, for the purposes of this sentence only, does not include a “Combination Product”) in combination with another compound or product (including the use of a Compound or a Product as part of a Combination Product), such inclusion shall not cause “Takeda Patents” to include any other Patents owned or Controlled by Takeda that Cover such other compound or product or the use or manufacture of such other compound or product (or the other active component of a Combination Product) that is not a Compound or a Product.
Takeda Patents shall include any Patent Controlled by Takeda or any of its Affiliates at any time during the Term that claims an Invention that is necessary or useful to Exploit the Compound or any Product in the Field in the Territory and is conceived and/or reduced to practice solely by, or on behalf of, Takeda or any of its Affiliates in the course of Takeda’s conduct of the Research Material Synthesis Activities.
Takeda Patents has the meaning set forth in Section 1.113 of the Takeda Agreement. “Territory” has the meaning set forth in Section 1.116 of the Takeda Agreement. “Third Party Claim” has the meaning set forth in Section 7.4(a). “Transaction Documents” means this Agreement, the Escrow Agreement, the Bill of Sale, the Takeda Consent and the Instruction Letter. “UCC” means the Uniform Commercial Code as in effect from time to time in the State of New York; provided, that, if, with respect to any financing statement or by reason of any provisions of applicable Law, the perfection or the effect of perfection or non-perfection of the back-up security interest or any portion thereof granted pursuant to Section 2.1(b) is governed by the Uniform Commercial Code as in effect in a jurisdiction of the United States other than the State of New York, then “UCC” means the Uniform Commercial Code as in effect from time to time in such other jurisdiction for purposes of the provisions of this Agreement and any financing statement relating to such perfection or effect of perfection or non-perfection. “U.S.” or “United States” means the United States of America, each territory thereof and the District of Columbia. “U.S.-Japan Tax Treaty” means the Convention Between the Government of the United States of America and the Government of Japan for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion With Respect to Taxes on Income, dated November 6, 2003, as amended by protocol dated January 24, 2013. “Valid Claim” means, with respect to a particular country, any claim of: (i) an issued and unexpired patent in such country that (a) has not been permanently revoked or held unenforceable or invalid by a decision of a Governmental Authority, which decision is unappealable or unappealed within the time allowed for appeal, and (b) has not been abandoned, disclaimed, denied or admitted to be invalid or unenforceable through reexamination, opposition, reissue or disclaimer or otherwise in such country; or (ii) a patent application in such country (which application is for a patent that has been pending less than [***] from the earliest date on which such patent application claims priority and which has not been cancelled, withdrawn, abandoned or finally rejected by an administrative agency action from which no appeal can be taken) if it were issued as a patent. Section 1.2
Takeda Patents means (a) the patents and patent applications that are Controlled by Takeda or any of its Affiliates as of the Effective Date and that are listed in Exhibit C together with (b) any and all provisionals, substitutions, extensions, divisionals, continuations, continuations-in-part, and foreign counterparts of any such patent applications described in (a) and (c) any and all patents which issue or are granted on any of the foregoing described in (a) or (b) anywhere in the world, including any extension, supplemental protection certificate, registration, confirmation, renewal and reexamined and reissued patents.
Takeda Patents means to the extent Controlled by Takeda or any of its Affiliates at any time during the Term, all Patents that Cover any
Takeda Patents. MEANS PATENTS CONTROLLED BY TAKEDA OR ITS AFFILIATES AS OF THE EFFECTIVE DATE OR DURING THE TERM THAT ARE REASONABLY NECESSARY TO EXPLOIT A COLLABORATION COMPOUND, COLLABORATION PRODUCT, OR COMPANION DIAGNOSTIC DIRECTED TO ANY COLLABORATION TARGET IN THE FIELD IN THE TERRITORY, EXCLUDING JOINT COLLABORATION PATENTS, PATENTS THAT COVER ANY OF THE TAKEDA Improvements, and any Patents included in the Takeda Collaboration IP. Schedule 1.283 PROVIDES A LISTING OF PATENTS THAT ARE CONTROLLED BY TAKEDA OR ITS AFFILIATES AS OF THE EFFECTIVE DATE AND THEREFORE WILL BE TAKEDA PATENTS TO THE EXTENT THAT THEY ARE REASONABLY NECESSARY TO EXPLOIT A COLLABORATION COMPOUND, COLLABORATION PRODUCT, OR COMPANION DIAGNOSTIC DIRECTED TO ANY Collaboration Target in the Field in the Territory.